Skip to main content

Halozyme Therapeutic (NQ: HALO )

50.66 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2024 Add to My Watchlist

Other Filings

Form DEF 14A
Source: SEC/Edgar
April 10, 2013
Form DEFA14A
Source: SEC/Edgar
April 10, 2013
Form 8-K
Source: SEC/Edgar
March 27, 2013
Form PRE 14A
Source: SEC/Edgar
March 17, 2013
Form 8-K
Source: SEC/Edgar
February 24, 2013
Form SC 13G/A
Source: SEC/Edgar
February 13, 2013
Form 8-K
Source: SEC/Edgar
January 06, 2013
Form 8-K
Source: SEC/Edgar
January 03, 2013
Form 8-K
Source: SEC/Edgar
December 04, 2012
Form 8-K
Source: SEC/Edgar
November 07, 2012
Form 8-K
Source: SEC/Edgar
October 01, 2012
Form 8-K
Source: SEC/Edgar
August 05, 2012
Form SC 13D/A
Source: SEC/Edgar
June 05, 2012
Form 8-K
Source: SEC/Edgar
May 06, 2012
Form DEF 14A
Source: SEC/Edgar
March 28, 2012
Form 8-K
Source: SEC/Edgar
March 08, 2012
Form SC 13G/A
Source: SEC/Edgar
February 13, 2012
Form SC 13D/A
Source: SEC/Edgar
February 12, 2012
Form 8-K
Source: SEC/Edgar
February 09, 2012
Form 424B5
Source: SEC/Edgar
February 09, 2012
Form 424B5
Source: SEC/Edgar
February 08, 2012
Form S-3ASR
Source: SEC/Edgar
February 08, 2012
Form 8-K
Source: SEC/Edgar
January 08, 2012
Form 8-K
Source: SEC/Edgar
December 11, 2011
Form 8-K
Source: SEC/Edgar
November 06, 2011
Form SC 13D/A
Source: SEC/Edgar
August 16, 2011
Form 8-K
Source: SEC/Edgar
August 04, 2011
Form 8-K
Source: SEC/Edgar
June 15, 2011
Form 8-K
Source: SEC/Edgar
May 10, 2011
Form 8-K
Source: SEC/Edgar
May 05, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.